Results 11 to 20 of about 1,673 (95)
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded [PDF]
Infectious Agents and CancerSeveral high-risk types of human papillomaviruses (HPVs) are associated with cervical cancer and other malignancies. Despite the tremendous success of marketed prophylactic HPV vaccines for the past 18 years, cervical cancer remains a significant global ...
Sogand Amiri +7 more
doaj +2 more sources
Prevalence, Characteristics, and Distribution of Human Papillomavirus According to Age and HIV Status in Women of Eastern Cape Province, South Africa [PDF]
VirusesHuman papillomavirus (HPV) is a sexually transmitted infection associated with the development of cervical cancer. This study investigated cervical HPV prevalence, characteristics, and distribution according to age and human immunodeficiency virus (HIV ...
Zizipho Z. A. Mbulawa +4 more
doaj +2 more sources
Vaccines, 2023 Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL® hereafter referred to as ...
Esperança Lourenço Guimarães +13 more
doaj +1 more source
PLoS ONE, 2022 Human papillomavirus (HPV) prevalence and genotype distribution data is important for HPV vaccine monitoring. This study investigated the prevalence and distribution of HPV genotypes in cervical lesions of unvaccinated women referred to Nelson Mandela ...
Zizipho Z A Mbulawa +4 more
doaj +2 more sources
Capsomer vaccines protect mice from vaginal challenge with human papillomavirus. [PDF]
PLoS ONE, 2011 Capsomers were produced in bacteria as glutathione-S-transferase (GST) fusion proteins with human papillomavirus type 16 L1 lacking the first nine and final 29 residues (GST-HPV16L1Δ) alone or linked with residues 13-47 of HPV18, HPV31 and HPV45 L2 in ...
Wai-Hong Wu +7 more
doaj +1 more source
Adjuvants in vaccines registered for human use [PDF]
Arhiv za farmaciju, 2019 Vaccination is one of the most efficient strategies for prevention of infection diseases, but with introduction of sub-unit vaccines with lower immunogenicity adjuvants were needed to enhance the immune response.
Filipić Brankica +1 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2021 ContextIt has been more than 10 years since the human papillomavirus (HPV) vaccination program was initiated in most advanced countries. Thus, it seems necessary to change the uterine cervical cancer screening strategy.
Javier Freire-Salinas +8 more
doaj +1 more source
PLoS ONE, 2021 As part of the human papillomavirus (HPV) vaccination strategy in South Africa, it is essential to have information on HPV prevalence, and HPV types distribution among the unvaccinated population. Information on the prevalence of HPV and the distribution
Zizipho Z A Mbulawa +3 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2017 One hundred and ninety eight females aged 12–15 y were enrolled in an observer-blinded randomized trial to assess the immunogenicity and reactogenicity of the tetravalent HPV vaccine Gardasil® (group 2), in comparison to the bivalent HPV vaccine ...
Tao Haskins-Coulter +3 more
doaj +1 more source
Papillomavirus Research, 2020 Human papillomavirus (HPV) causes not only most cervical cancers but also cancers of the vagina, vulva, penis, anus, rectum, and oropharynx. Every year, 200,000 women die of cervical cancer in the world, and China accounts for about 10%. HPV vaccines are
Yan Wang +5 more
doaj +1 more source